Skip to main content
Download PDF

Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

BMC Psychiatry volume 5, Article number: 44 (2005) Cite this article

The Original Article was published on 24 January 2005

The comment in the introduction of our article [1] suggesting that "quetiapine is the only available antipsychotic with significant 5-HT1D effects," is misleading. The affinity of quetiapine for this receptor is low and probably insignificant when compared with some other second generation antipsychotics [2].

References

  1. Carey PD, Vythilingum B, Seedat S, Muller JE, van AM, Stein DJ: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry. 2005, 5: 5-10.1186/1471-244X-5-5.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Richelson E, Souder T: Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 2000, 68: 29-39. 10.1016/S0024-3205(00)00911-5.

    Article  CAS  PubMed  Google Scholar 

Pre-publication history

Download references

Author information

Authors and Affiliations

  1. MRC Research Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa

    Paul D Carey, Bavanisha Vythilingum, Soraya Seedat, Jacqueline E Muller & Dan J Stein

  2. Department of Psychiatry and Behavioral Neurosciences, McMaster University, Hamilton, Ontario, Canada

    Michael van Ameringen

Authors
  1. Paul D Carey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bavanisha Vythilingum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Soraya Seedat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jacqueline E Muller
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael van Ameringen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dan J Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul D Carey.

Additional information

The online version of the original article can be found at 10.1186/1471-244X-5-5

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Carey, P.D., Vythilingum, B., Seedat, S. et al. Erratum to: Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry 5, 44 (2005). https://doi.org/10.1186/1471-244X-5-44

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1471-244X-5-44

BMC Psychiatry

ISSN: 1471-244X

Contact us